Physician profile
Audrey E Steinkamp
NPI 1053567115
$2,612.33
in general payments reported to CMS, 2019-2025
34 companies · $567 in 2025
The $567 reported for 2025 was more than what 89% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $588 · 2022: $764 · 2023: $368 · 2024: $325 · 2025: $567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,260.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $353.80 | 2021-2023 | |
| Aspira Women'S Health INC | $240.95 | 2022-2025 | Ova1 |
| Organon LLC | $238.95 | 2021-2025 | Nexplanon, Jada System |
| Bayer Healthcare Pharmaceuticals INC. | $214.48 | 2022-2025 | |
| Coopersurgical, INC. | $117.32 | 2021-2025 | Paragard T 380a, Paragard T 380a |
| Astellas Pharma US INC | $116.24 | 2024-2025 | Veozah |
| Biogen, INC. | $109.29 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $105.51 | 2022-2025 | |
| Shield Therapeutics INC | $103.18 | 2023-2025 | Accrufer |
| Hologic Sales and Service, LLC | $91.56 | 2021-2023 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Amgen INC. | $85.75 | 2021-2022 | |
| Daiichi Sankyo INC. | $77.79 | 2021-2022 | |
| Millicent US INC | $67.19 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Evofem Biosciences, INC. | $60.62 | 2021 | |
| Merck Sharp & Dohme LLC | $51.64 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $49.57 | 2022 | |
| Exact Sciences Corporation | $44.47 | 2025 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $44.45 | 2021-2022 | |
| Alfasigma USA, INC. | $43.88 | 2021 | |
| Therapeuticsmd, INC. | $39.23 | 2021-2022 | |
| Channel Medsystems, INC. | $37.40 | 2022 | |
| Pfizer INC. | $36.63 | 2025 | |
| Mylan Pharmaceuticals INC. | $35.53 | 2021 | |
| Agile Therapeutics, INC. | $33.88 | 2021 | |
| Gynesonics, INC. | $32.35 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Scynexis, INC. | $26.66 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $23.27 | 2023 | Vivjoa |
| Ibsa Pharma INC. | $20.95 | 2024 | Tirosint, Licart |
| Dexcom, INC. | $20.69 | 2024 | Dexcom G6 Transmitter |
| Seqirus USA INC | $18.56 | 2022 | |
| Boston Scientific Corporation | $18.31 | 2021 | |
| Becton, Dickinson and Company | $18.15 | 2025 | Bd Onclarity |
| Pacira Pharmaceuticals Incorporated | $17.84 | 2021 | |
| Myovant Sciences INC. | $16.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Steinkamp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.